These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 25865119)

  • 21. In-depth genomic data analyses revealed complex transcriptional and epigenetic dysregulations of BRAFV600E in melanoma.
    Guo X; Xu Y; Zhao Z
    Mol Cancer; 2015 Mar; 14():60. PubMed ID: 25890285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EMT-associated factors promote invasive properties of uveal melanoma cells.
    Asnaghi L; Gezgin G; Tripathy A; Handa JT; Merbs SL; van der Velden PA; Jager MJ; Harbour JW; Eberhart CG
    Mol Vis; 2015; 21():919-29. PubMed ID: 26321866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Epigenetic regulation of gene expression in malignant melanoma].
    Laurette P; Koludrovic D; Coassolo S; Davidson I
    Biol Aujourdhui; 2016; 210(4):283-295. PubMed ID: 28327285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Down-regulation of ARID1A is sufficient to initiate neoplastic transformation along with epigenetic reprogramming in non-tumorigenic endometriotic cells.
    Lakshminarasimhan R; Andreu-Vieyra C; Lawrenson K; Duymich CE; Gayther SA; Liang G; Jones PA
    Cancer Lett; 2017 Aug; 401():11-19. PubMed ID: 28483516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MITF pathway mutations in melanoma.
    Yokoyama S; Salma N; Fisher DE
    Pigment Cell Melanoma Res; 2009 Aug; 22(4):376-7. PubMed ID: 19558635
    [No Abstract]   [Full Text] [Related]  

  • 26. MITF, the Janus transcription factor of melanoma.
    Koludrovic D; Davidson I
    Future Oncol; 2013 Feb; 9(2):235-44. PubMed ID: 23414473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin-like EMT inducer regulates partial phenotype switching in MITF-low melanoma cell lines.
    Noguchi K; Dalton AC; Howley BV; McCall BJ; Yoshida A; Diehl JA; Howe PH
    PLoS One; 2017; 12(5):e0177830. PubMed ID: 28545079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenetic regulation in human melanoma: past and future.
    Sarkar D; Leung EY; Baguley BC; Finlay GJ; Askarian-Amiri ME
    Epigenetics; 2015; 10(2):103-21. PubMed ID: 25587943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chromatin modifiers and tumor suppression.
    Klochendler-Yeivin A; Yaniv M
    Biochim Biophys Acta; 2001 Aug; 1551(1):M1-10. PubMed ID: 11553416
    [No Abstract]   [Full Text] [Related]  

  • 30. Overcoming MITF-conferred drug resistance through dual AURKA/MAPK targeting in human melanoma cells.
    Pathria G; Garg B; Borgdorff V; Garg K; Wagner C; Superti-Furga G; Wagner SN
    Cell Death Dis; 2016 Mar; 7(3):e2135. PubMed ID: 26962685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microphthalmia-associated transcription factor expression levels in melanoma cells contribute to cell invasion and proliferation.
    Vachtenheim J; Ondrušová L
    Exp Dermatol; 2015 Jul; 24(7):481-4. PubMed ID: 25866058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mitf regulation of Dia1 controls melanoma proliferation and invasiveness.
    Carreira S; Goodall J; Denat L; Rodriguez M; Nuciforo P; Hoek KS; Testori A; Larue L; Goding CR
    Genes Dev; 2006 Dec; 20(24):3426-39. PubMed ID: 17182868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AP-1 and C/EBP transcription factors contribute to mda-7 gene promoter activity during human melanoma differentiation.
    Madireddi MT; Dent P; Fisher PB
    J Cell Physiol; 2000 Oct; 185(1):36-46. PubMed ID: 10942517
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Ennen M; Keime C; Gambi G; Kieny A; Coassolo S; Thibault-Carpentier C; Margerin-Schaller F; Davidson G; Vagne C; Lipsker D; Davidson I
    Clin Cancer Res; 2017 Nov; 23(22):7097-7107. PubMed ID: 28855355
    [No Abstract]   [Full Text] [Related]  

  • 35. Brn-2 represses microphthalmia-associated transcription factor expression and marks a distinct subpopulation of microphthalmia-associated transcription factor-negative melanoma cells.
    Goodall J; Carreira S; Denat L; Kobi D; Davidson I; Nuciforo P; Sturm RA; Larue L; Goding CR
    Cancer Res; 2008 Oct; 68(19):7788-94. PubMed ID: 18829533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MLANA/MART1 and SILV/PMEL17/GP100 are transcriptionally regulated by MITF in melanocytes and melanoma.
    Du J; Miller AJ; Widlund HR; Horstmann MA; Ramaswamy S; Fisher DE
    Am J Pathol; 2003 Jul; 163(1):333-43. PubMed ID: 12819038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypoxia-inducible factor 1{alpha} is a new target of microphthalmia-associated transcription factor (MITF) in melanoma cells.
    Buscà R; Berra E; Gaggioli C; Khaled M; Bille K; Marchetti B; Thyss R; Fitsialos G; Larribère L; Bertolotto C; Virolle T; Barbry P; Pouysségur J; Ponzio G; Ballotti R
    J Cell Biol; 2005 Jul; 170(1):49-59. PubMed ID: 15983061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Robust gene expression programs underlie recurrent cell states and phenotype switching in melanoma.
    Wouters J; Kalender-Atak Z; Minnoye L; Spanier KI; De Waegeneer M; Bravo González-Blas C; Mauduit D; Davie K; Hulselmans G; Najem A; Dewaele M; Pedri D; Rambow F; Makhzami S; Christiaens V; Ceyssens F; Ghanem G; Marine JC; Poovathingal S; Aerts S
    Nat Cell Biol; 2020 Aug; 22(8):986-998. PubMed ID: 32753671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sox10 controls migration of B16F10 melanoma cells through multiple regulatory target genes.
    Seong I; Min HJ; Lee JH; Yeo CY; Kang DM; Oh ES; Hwang ES; Kim J
    PLoS One; 2012; 7(2):e31477. PubMed ID: 22363655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SMARCA4 promotes benign skin malignant transformation into melanoma through Adherens junction signal transduction.
    Liu SR; Yang X; Qi L; Zhu Z; Ji YZ
    Clin Transl Oncol; 2021 Mar; 23(3):591-600. PubMed ID: 32720055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.